Dr. Christian Geiß

Medizinisch-wissenschaftlicher Außendienst (KOL Management) für das gesamte General Medicines Portfolio von Sanofi (Diabetes, Herz-Kreislauf (Lipidmanagement), Schilddrüse und Blutgerinnung) und Progression der Digitalen Transformation in der Medizin (Digital Healthcare (DHC), Digitale Gesundheitsanwendungen (DiGAs), Telemedizin (TMZ) und Remote Patient Management (RPM)).

Field pharmaceutical consultant engaged in consulting diabetologists in surgery and gastroenterologists (senior/chief physicians) in the clinical field at treating diabetes & obesity.

Field pharmaceutical consultant engaged in consulting GPIS at treating diabetes, symptomatic hyperuricaemia and cardiovascular risk-factors such as hypercholesterinaemia.

I worked on three international projects in the field of 3D-cryo electron microscopy engaged in the structural elucidation of centromeric chromatin, genetically engineered viral vaccines and the role of RNA polymerase I in yeast as first regulative step in ribosome biogenesis.

Establishment & application of a 2D-nanoLC-based mass spectrometry-coupled system for the quantitative analysis of COPI-vesicles & the synaptic plasticity of hippocampal neurons.

My professional assignment included to work in a chemical substance bibliography in order to inventory (classify) chemicals into a Microsoft Access database that was also operated by SQL scripts.

My professional assignment included to work with chemical technicians and biotechnologists in a team on the optimization of chemical processes during the large-scale synthesis of the oral antidiabeticum precursor Glimepirid-Urethan.

3D-Cryo Electron Micropscopy, Electron Tomography, Structural Biology, Computational Biology

Molecular Biology, Biochemsitry, Cell Biology, Genetics, Microbiology, Analytical and Anorganic Chemistry, Mass Spectrometry, Proteomics

Molecular Biology, Biochemistry, Genetics, Cell Biology